Trinity to host new research on how immune system repairs brain

The funding means that over the next five years, Prof. Fitzgerald – who has, until now, been based exclusively in Queen’s University Belfast – will lead a research team of ten based in Trinity and partnering with the FutureNeuro Research Ireland Centre for Translational Brain Science, St James’s Hospital, and Beaumont Hospital to discover why our immune cells become less able to coax brain stem cells to repair damage as we age.

This research combines immunology, neuroscience and regenerative biology to tackle this complex problem.

Prof. Fitzgerald said: “This ambitious programme of research will uncover new insights into fundamental changes in the older immune system that has a knock-on effect on brain repair. This new knowledge can then be used to develop pioneering regenerative treatment for MS and other neurological conditions.

“To speed this up, we are embedding research into new clinical trials led by consultant neurologist, Hugh Kearney. This will increase the opportunities for people with MS in Ireland to access experimental treatments early, as well as to co-produce research with us as key public members of the research programme. Through this neuroimmunology research programme we will train the next generation of scientists, doctors and health professionals, side-by-side, in partnership with the public.”

Dr Diarmuid O’Brien, CEO of Research Ireland, said: “Research Ireland is pleased to support Prof. Fitzgerald’s critically important work over the next five years, with the investment   facilitating an additional 11 research positions, comprising postdocs, PhDs, research assistants and senior research fellows. Funding excellent research talent is a key part of our recently launched strategy, as is addressing Ireland’s opportunities and challenges in areas such as public health. I look forward to seeing the outputs and impact of Prof. Fitzgerald’s endeavours over the coming years.”

Through this appointment, Prof. Fitzgerald will divide her role between Trinity and Queen’s University Belfast, promoting all-island collaboration across neuroimmunology and other research areas. She will be an investigator at FutureNeuro, the RCSI-based Research Ireland Centre that aims to translate breakthroughs in understanding of brain structure and function to transform the patient journey for people with neurological diseases.

She also brings extensive international collaboration with world-leading experts at Cambridge University, University College London, the University of Toronto, the Institute of Neuroscience – Alicante, the Wellcome Sanger Institute and Maynooth University.

Prof. Colin Doherty, head of the School of Medicine in Trinity and a Principal Investigator with FutureNeuro, said: “I have known Denise for some time and have marvelled at the quality of her research into one of the great and challenging areas of medical science. We are delighted that she will be leading a team here in Trinity while retaining her links with Queen’s, strengthening all-island collaboration in neuroimmunology and creating exciting new opportunities across the wider FutureNeuro research network.”

Media Contact:

Thomas Deane | Media Relations | deaneth@tcd.ie | +353 1 896 4685